RASSF1A and ERCC1 Expression Levels Might Be Predictive of Prognosis in Advanced, Recurrent, and Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with Docetaxel and Cisplatin

Publisher： Karger

E-ISSN： 2296-5262|35|11|673-682

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.35, Iss.11, 2012-10, pp. : 673-682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive Role of ERCC1 Expression in Head and Neck Squamous Cell Carcinoma Patients Treated with Surgery and Adjuvant Cisplatin-Based Chemoradiation

By  

Oncology, Vol. 89, Iss. 4, 2015-06 ,pp. : 227-234

Karger

Access to resources Recommend Favorite

Phase II Study with Docetaxel and Cisplatin in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

By  

Oncology, Vol. 63, Iss. 2, 2002-09 ,pp. : 145-150

Karger

Access to resources Recommend Favorite

Vinorelbine and Carboplatin in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis

By Pavelić K.   Kapitanović S.   Radošević S.   Bura M.   Seiwerth S.   Pavelić L.J.   Unušić J.   Spaventi R.  

Journal of Molecular Medicine, Vol. 78, Iss. 2, 2000-02 ,pp. : 111-118

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of circulating tumor cells with podoplanin expression in patients with locally advanced or metastatic head and neck squamous cell carcinoma

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 10, 2015-10 ,pp. : 1448-1455

John Wiley & Sons Inc

Access to resources Recommend Favorite